efavirenz and Addiction, Opioid

efavirenz has been researched along with Addiction, Opioid in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Alvanzo, A; Baker, J; Friedland, G; Jatlow, P; McCance-Katz, EF; Moody, DE; Morse, GD; Ogundele, A; Pade, P; Rainey, PM; Smith, P	1
Eap, CB	1

Other Studies

2 other study(ies) available for efavirenz and Addiction, Opioid

Article	Year
Interactions between buprenorphine and antiretrovirals. I. The nonnucleoside reverse-transcriptase inhibitors efavirenz and delavirdine. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2006, Dec-15, Volume: 43 Suppl 4 Topics: Adult; Alkynes; Area Under Curve; Benzoxazines; Buprenorphine; Case-Control Studies; Cohort Studies; Cyclopropanes; Delavirdine; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Interactions; Female; HIV Infections; Humans; Male; Narcotic Antagonists; Opioid-Related Disorders; Oxazines; Probability; Prognosis; Reference Values; Reverse Transcriptase Inhibitors; Risk Assessment; Statistics, Nonparametric; Treatment Outcome	2006
Comment: opiate withdrawal symptoms induced by antiretroviral drugs. The Annals of pharmacotherapy, 2000, Volume: 34, Issue:9 Topics: Alkynes; Analgesics, Opioid; Anti-HIV Agents; Benzoxazines; Cyclopropanes; Humans; Methadone; Nevirapine; Opioid-Related Disorders; Oxazines; Substance Withdrawal Syndrome	2000

Article

Year

Interactions between buprenorphine and antiretrovirals. I. The nonnucleoside reverse-transcriptase inhibitors efavirenz and delavirdine.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2006, Dec-15, Volume: 43 Suppl 4

Topics: Adult; Alkynes; Area Under Curve; Benzoxazines; Buprenorphine; Case-Control Studies; Cohort Studies; Cyclopropanes; Delavirdine; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Interactions; Female; HIV Infections; Humans; Male; Narcotic Antagonists; Opioid-Related Disorders; Oxazines; Probability; Prognosis; Reference Values; Reverse Transcriptase Inhibitors; Risk Assessment; Statistics, Nonparametric; Treatment Outcome

2006

Comment: opiate withdrawal symptoms induced by antiretroviral drugs.

The Annals of pharmacotherapy, 2000, Volume: 34, Issue:9

Topics: Alkynes; Analgesics, Opioid; Anti-HIV Agents; Benzoxazines; Cyclopropanes; Humans; Methadone; Nevirapine; Opioid-Related Disorders; Oxazines; Substance Withdrawal Syndrome

2000